XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 86,453 $ 65,133 $ 163,394 $ 126,478
General and administrative 37,089 30,740 70,126 60,052
Total operating expenses 123,542 95,873 233,520 186,530
Loss from operations (123,542) (95,873) (233,520) (186,530)
Other income (loss):        
Interest expense (602) (607) (1,202) (1,207)
Interest income 7,319 1,510 13,596 2,326
Other income (expense) 318 133 (12) 221
Total other income 7,035 1,036 12,382 1,340
Net loss (116,507) (94,837) (221,138) (185,190)
Less: Net income (loss) attributable to non-controlling interest, net of tax of $0 14 (8) 30 (9)
Net loss attributable to common stockholders (116,521) (94,829) (221,168) (185,181)
Net loss (116,507) (94,837) (221,138) (185,190)
Other comprehensive income (loss):        
Unrealized gain (loss) on marketable securities 2,640 (3,321) 8,158 (14,937)
Total comprehensive loss (113,867) (98,158) (212,980) (200,127)
Less: Comprehensive income (loss) attributable to non-controlling interest 14 (8) 30 (9)
Comprehensive loss attributable to common stockholders $ (113,881) $ (98,150) $ (213,010) $ (200,118)
Net loss per share - Basic $ (0.26) $ (0.22) $ (0.5) $ (0.43)
Net loss per share - Diluted $ (0.26) $ (0.22) $ (0.5) $ (0.43)
Weighted-average common shares outstanding - Basic 445,324 431,523 442,724 430,435
Weighted-average common shares outstanding - Diluted 445,324 431,523 442,724 430,435